Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Journal of Biomedicine & Biotechnology|December 14, 2011
Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypesTheophanis P Karageorgas, Dimitrios D Tseronis, Clio P Mavragani
Journal of Autoimmunity|June 15, 2012
Endocrine alterations in primary Sjogren's syndrome: an overviewClio P Mavragani, George E Fragoulis, Haralampos M Moutsopoulos
Current Opinion in Immunology|June 13, 2026
Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancyHaralampos M Moutsopoulos, Ilir I Cinoku, Clio P Mavragani
Nature Clinical Practice. Rheumatology|August 26, 2006
The management of Sjögren's syndromeClio P Mavragani, Niki M Moutsopoulos, Haralampos M Moutsopoulos
Frontiers in Psychiatry|July 5, 2018
Anxiety and Extraversion in Lupus-Related AtherosclerosisMaira Giannelou, Dimitrios Tseronis, Eleni Antypa, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activation of type I interferon in systemic lupus erythematosusKyriakos A Kirou, Clio P Mavragani, Mary K Crow
Journal of Clinical Medicine|March 10, 2022
Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren's SyndromeCharalampos Skarlis, Adrianos Nezos, Antonios Chatzigeorgiou, et al.
The Journal of Rheumatology|July 17, 2009
Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndromeClio P Mavragani, Fotini N Skopouli, Haralampos M Moutsopoulos
Expert Opinion on Therapeutic Targets|August 29, 2012
Ocular actions of platelet-activating factor: clinical implicationsEirini Nitoda, Marilita M Moschos, Clio P Mavragani, et al.
Expert Review of Clinical Immunology|June 18, 2025
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an updateSylvia Raftopoulou, Ioanna Kapsali, Maria-Eleftheria Evangelopoulos, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Journal of Biomedicine & Biotechnology|December 14, 2011
Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypesTheophanis P Karageorgas, Dimitrios D Tseronis, Clio P Mavragani
Journal of Autoimmunity|June 15, 2012
Endocrine alterations in primary Sjogren's syndrome: an overviewClio P Mavragani, George E Fragoulis, Haralampos M Moutsopoulos
Current Opinion in Immunology|June 13, 2026
Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancyHaralampos M Moutsopoulos, Ilir I Cinoku, Clio P Mavragani
Nature Clinical Practice. Rheumatology|August 26, 2006
The management of Sjögren's syndromeClio P Mavragani, Niki M Moutsopoulos, Haralampos M Moutsopoulos
Frontiers in Psychiatry|July 5, 2018
Anxiety and Extraversion in Lupus-Related AtherosclerosisMaira Giannelou, Dimitrios Tseronis, Eleni Antypa, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activation of type I interferon in systemic lupus erythematosusKyriakos A Kirou, Clio P Mavragani, Mary K Crow
Journal of Clinical Medicine|March 10, 2022
Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren's SyndromeCharalampos Skarlis, Adrianos Nezos, Antonios Chatzigeorgiou, et al.
The Journal of Rheumatology|July 17, 2009
Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndromeClio P Mavragani, Fotini N Skopouli, Haralampos M Moutsopoulos
Expert Opinion on Therapeutic Targets|August 29, 2012
Ocular actions of platelet-activating factor: clinical implicationsEirini Nitoda, Marilita M Moschos, Clio P Mavragani, et al.
Expert Review of Clinical Immunology|June 18, 2025
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an updateSylvia Raftopoulou, Ioanna Kapsali, Maria-Eleftheria Evangelopoulos, et al.
Pageof 12